/PRNewswire/ Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2023 results. "We were very pleased with the overall execution on.
Undertaking a major business transformation is never easy. It’s even tougher when initiated in a year subject to multiple macroeconomic uncertainties like the [.]